Catalog Number 545050501 |
Device Problem
Loss of or Failure to Bond (1068)
|
Patient Problems
Pain (1994); No Information (3190); No Code Available (3191)
|
Event Date 10/20/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
This complaint is still under investigation.Depuy will notify the fda of the results of this investigation once it has been completed.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.(b)(4).
|
|
Event Description
|
Patient was revised to address tibial loosening at both interface.Depuy cement was used.
|
|
Manufacturer Narrative
|
No device associated with this report was received for examination.A worldwide complaint database search found no other reported incident(s) against the provided product/lot combination(s) since release for distribution.Based on previous investigations this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.(b)(4) has been undertaken to investigate further.Depuy considers the investigation closed at this time.Should the additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.
|
|
Event Description
|
Update rec'd 11/10/2015 - the patient's medical records were received.Medical records were reviewed for mdr reportability.According to the medical records, prior to being revised the patient developed pain.There is no new information that would change the existing mdr decision.The complaint was updated on: 12/02/2015.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: dmf# - 13704, trade name ¿ gentamicin sulphate, active ingredient(s) ¿ gentamicin sulphate, dosage form - powder, strength ¿ 1.0g active in our cements.No code available (3191) is used to capture device evision or replacement.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot : a previous device history record (dhr) review was conducted by the manufacturing site on (b)(4).The dhr review revealed of the (b)(4) unit batch, no non-conformance of this lot was identified.Final micro and sterility tests passed.There were no anomalies associated with this lot.
|
|
Search Alerts/Recalls
|